Clinical Trials Logo

Clinical Trial Summary

Identifying hypercortisolism patients at risk for cardio-vascular events despite biological cure, and determine which patients should be particularly followed. Hypercortisolic patients represent an ideal in vivo model to determine the interactions between glucocorticoids and ectopic fat development.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02335996
Study type Interventional
Source Assistance Publique Hopitaux De Marseille
Contact
Status Completed
Phase N/A
Start date December 8, 2014
Completion date May 25, 2023

See also
  Status Clinical Trial Phase
Terminated NCT03379363 - Retrospective Chart Review Study of Pediatric Patients Treated With Korlym for Cushing Syndrome
Recruiting NCT04045015 - Liquorice and Salivary Cortisol N/A
Recruiting NCT06430528 - A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement
Recruiting NCT05772169 - Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST) Phase 4
Recruiting NCT05368090 - Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism N/A
Not yet recruiting NCT06246357 - Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism Phase 2
Not yet recruiting NCT04433819 - Nailfold Capillaroscopy Evaluation in Cushing Syndrome Patients
Active, not recruiting NCT04308590 - Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas Phase 3
Recruiting NCT04127552 - Impact of Adrenal IncidenTalomas and Possible Autonomous Cortisol Secretion on Cardiovascular and Metabolic Alterations
Recruiting NCT05255900 - Effects of Metyrapone in Patients With Hypercortisolism
Recruiting NCT05766085 - Cortisol Secretion, Sensitivity and Activity and Hypertension